| 1 |
27934636 | Impact of Probe Substrate Selection on Cytochrome P450 Reaction Phenotyping Using the Relative Activity Factor. | 2017 Feb |
1 |
| 2 |
28073119 | In Vitro Inhibition of Human CYP450s 1A2, 2C9, 3A4/5, 2D6 and 2E1 by Grandisin. | 2017 May |
1 |
| 3 |
23287855 | Heterologous expression of CYP102A5 variant from Bacillus cereus CYPPB-1: Validation of model for predicting drug metabolism of human P450 probe substrates. | 2013 Sep |
1 |
| 4 |
20809476 | Effect of fluvastatin, lovastatin, nifedipine and verapamil on the systemic exposure of nateglinide in rabbits. | 2010 Nov |
1 |
| 5 |
10948089 | Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. | 2000 Aug |
2 |
| 6 |
9929518 | Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes. | 1999 Feb |
1 |
| 7 |
10208645 | Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele. | 1999 Feb |
2 |
| 8 |
9186495 | Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions. | 1997 Jun 15 |
1 |